Cases & Deals

  • Home
  • Practices
  • ArunA Bio raises $13.3 million in Common Stock offering

Share

ArunA Bio raises $13.3 million in Common Stock offering

July 2019

Client(s) ArunA Bio, Inc.

Jones Day represented ArunA Bio, Inc., a manufacturer of technologies in human stem cell research for use in drug discovery and development, in connection with its offering and sale of up to $13.3 million of Common Stock. Proceeds from the financing will be used to support the continued development of ArunA Bio’s neural exosome delivery platform and pipeline of novel neural exosome therapies for the treatment of neurodegenerative diseases such as ALS and Huntington’s Disease, as well as stroke.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.